AXSM News and Press, Axsome Therapeutics Inc. From 09/06/22

NEW YORK, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced that Herriot Tabuteau, MD, Axsome’s Chief Executi...

Axsome Therapeutics ( NASDAQ: AXSM ) said it enrolled the first patient in a phase 3 trial of AXS-07 for the acute treatment of migraine. The study, dubbed EMERGE, will enroll ~100 patients to test the the efficacy and safety of AXS-07 in the acute treatment of migrain...

NEW YORK, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, announced that it has enrolled the first patient in the EMERGE trial of ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Editor’s Note : John and Wade here – today, we have a special guest issue from InvestorPlace’s own Luke Lango. The markets have slid following the Fed symposium in Jackson Hole over the weekend, and a ...

Axsome Therapeutics (NASDAQ: AXSM) stock recently shot higher on a generally lousy day for the overall stock market. The gains came in response to the FDA's approval of Auvelity, the first new line of treatment in years for millions of Americans with major depressive disorder. D...

Gainers: GigaCloud Technology Inc Class A Ordinary Shares ( GCT ) +173% . Volcon ( VLCN ) +74% . Axsome Therapeutics ( AXSM ) +40% . Endo International plc ( ENDP ) +24% . Foot Locker ( FL ) +21% . Summit Therapeutics ( ...

Shares of the commercial-stage healthcare company Axsome Therapeutics (NASDAQ: AXSM) were up by a handsome 31.4%, on heavy volume, as of 9:53 a.m. ET Friday. The stock price of the specialist in central nervous system disorders is shooting higher today in response to the Food an...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Shutterstock Volcon (NASDAQ: VLCN ) stock is rocketing higher on Friday after the electric vehicle (EV) company revealed massive pre-production orders for its Stag . The Stag is the first EV being mad...

Gainers: Axsome Therapeutics AXSM +31% . Summit Therapeutics SMMT +25% . Assure Holdings ( IONM ) +13% . Longboard Pharmaceuticals ( LBPH ) +10% . TransCode Therapeutics ( RNAZ ) +8% . Losers: Accelerate Diagnostics AXDX -27...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Shares of Axsome Therapeutics (NASDAQ: AXSM ) are up more than 30% today on news that the biopharmaceutical company has received approval from the U.S. Food and Drug Administration (FDA) for a unique, first-of-its-kin...